Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs

Serum iron levels have been reported to increase following the administration of various anticancer drugs. An increase in serum iron levels during therapy with leucovorin and fluorouracil plus oxaliplatin (FOLFOX) or leucovorin and fluorouracil plus irinotecan (FOLFIRI) was also observed. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: OCHIAI, TAKUMI, NISHIMURA, KAZUHIKO, WATANABE, TOMOO, KITAJIMA, MASAYUKI, NAKATANI, AKINORI, INOU, TAKASHI, SHIBATA, HIDEKI, SATO, TSUYOSHI, KISHINE, KENJI, SEO, SHOUGO, OKUBO, SATOSHI, FUTAGAWA, SHUNJI, MASHIKO, SATOMI, NAGAOKA, ISAO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916199/
https://www.ncbi.nlm.nih.gov/pubmed/24649250
http://dx.doi.org/10.3892/mco.2013.136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916199/
https://www.ncbi.nlm.nih.gov/pubmed/24649250
http://dx.doi.org/10.3892/mco.2013.136

Ejemplares similares